By Counterforce Health Team in Keppra (levetiracetam) —

How to Get Keppra (Levetiracetam) Covered by UnitedHealthcare in Washington: Complete Guide to Formulary Tiers, Prior Authorization & Appeals

Answer Box: Quick Path to Keppra Coverage

Generic levetiracetam is typically covered as Tier 1 (preferred generic) without prior authorization on most UnitedHealthcare plans in Washington. Brand Keppra requires prior authorization and medical necessity documentation. If denied, you have 180 days to file internal appeals, then external review through Washington's Independent Review Organization.

First steps: Check your specific plan's formulary, request generic levetiracetam first, and gather clinical documentation if brand is needed. Contact Washington's Office of the Insurance Commissioner at 1-800-562-6900 for appeal assistance.

Table of Contents

Plan Types & Network Requirements

UnitedHealthcare offers several plan types in Washington, each with different requirements for accessing neurologists and seizure medications:

Referral Requirements by Plan Type

Plan Type Referral for Neurology? Out-of-Network Coverage? Key Features
HMO Yes - PCP referral required Emergency only Lower premiums, coordinated care
PPO No - direct access Yes (higher cost) Flexibility, broader network
EPO No - direct access Emergency only Lower cost than PPO
Medicare Advantage HMO Usually Yes Limited Medicare + extras
Medicare Advantage PPO No Yes (higher cost) Medicare flexibility
Note: Always verify your specific plan type through your member portal or by calling the number on your insurance card, as requirements can vary by employer group or individual plan design.

Network Considerations

For seizure treatment in Washington, you'll want to ensure your neurologist is in-network. UnitedHealthcare's provider directory shows available specialists, but network adequacy can be limited in rural areas. If no in-network neurologist is available within a reasonable distance, you can request a network exception for coverage at in-network rates.

Formulary Status & Tier Placement

Current Formulary Position (2024-2025)

Generic levetiracetam is placed on Tier 1 (Preferred Generic) across most UnitedHealthcare commercial and Medicare plans, meaning:

  • Lowest copay tier (typically $5-15 for 30-day supply)
  • No prior authorization required
  • No quantity limits for standard dosing

Brand Keppra faces restrictions:

  • Higher tier placement (Tier 3-4) when covered
  • Prior authorization required
  • Must demonstrate medical necessity over generic

Alternative Seizure Medications

UnitedHealthcare's step therapy protocols may require trials of these alternatives before approving newer anticonvulsants:

  • Carbamazepine (generic Tegretol)
  • Divalproex (generic Depakote)
  • Lamotrigine (generic Lamictal)
  • Phenytoin (generic Dilantin)
  • Topiramate (generic Topamax)
  • Valproic acid (generic Depakene)

Prior Authorization & Step Therapy Rules

When Prior Authorization Is Required

Prior authorization for Keppra/levetiracetam typically applies when:

  • Requesting brand Keppra instead of generic
  • Exceeding standard quantity limits
  • Using for off-label indications
  • Prescribing specialty formulations (IV, extended-release)

Step Therapy Requirements

For newer, more expensive seizure medications, UnitedHealthcare requires documentation of:

  • At least two prior antiepileptic drug trials (including levetiracetam)
  • Minimum 8-week trial duration for each medication
  • Clear documentation of failure (lack of efficacy or intolerable side effects)
  • Reasonable attempts to manage side effects before discontinuation

Medical Necessity Criteria for Brand Keppra

To obtain coverage for brand Keppra over generic levetiracetam, you must document:

  • Adverse reaction to generic formulation ingredients
  • Seizure worsening after generic switch
  • Inability to achieve therapeutic levels with generic
  • Documented intolerance to generic excipients

Specialty Pharmacy Requirements

UnitedHealthcare routes certain seizure medications through OptumRx Specialty Pharmacy, particularly:

  • High-cost formulations
  • IV levetiracetam for home infusion
  • Specialty seizure medications requiring step therapy

Patient Setup Process

  1. Prescription routing: Provider submits to OptumRx Specialty
  2. Benefits verification: OptumRx confirms coverage and copay
  3. Prior authorization: Submitted electronically when required
  4. Patient enrollment: Direct contact for delivery coordination
  5. Ongoing support: Medication management and refill coordination

Cost-Share Dynamics

Typical Cost Structure

Generic levetiracetam (Tier 1):

  • Copay plans: $5-15 per 30-day supply
  • Coinsurance plans: 10-20% after deductible
  • High-deductible plans: Full cost until deductible met

Brand Keppra (when covered):

  • Copay plans: $40-80 per 30-day supply
  • Coinsurance plans: 25-40% after deductible
  • May require step therapy completion first

Cost-Saving Options

  • Generic substitution: Always request generic levetiracetam first
  • 90-day supplies: Often reduce per-dose costs
  • Mail-order pharmacy: May offer lower copays
  • Manufacturer programs: Check UCB's patient assistance programs

Submission Process & Forms

Electronic Prior Authorization (ePA)

Fastest option: Submit through your EMR's integrated ePA system

  • Platform: SureScripts™ ePA
  • Processing time: Often automated in minutes for standard requests
  • Status tracking: Real-time updates through provider portal

Manual Submission Options

OptumRx Prior Authorization:

  • Fax: 1-888-671-5285
  • Online: OptumRx Healthcare Professionals Portal
  • Phone: 1-800-711-4555 for urgent requests

Required Documentation

For any prior authorization:

  • Patient demographics and insurance information
  • Prescriber details and NPI
  • Medication details (strength, quantity, directions)
  • Diagnosis codes (ICD-10)
  • Clinical justification

For brand medical necessity:

  • Documentation of generic trial and outcome
  • Specific adverse reactions or lack of efficacy
  • Clinical notes supporting brand requirement

Common Approval Patterns

Strong Submissions Include

  1. Clear clinical timeline: Dates of seizure onset, previous treatments, outcomes
  2. Specific failure documentation: Why each prior medication was discontinued
  3. Objective measures: Seizure frequency, EEG results, medication levels
  4. Guideline alignment: Reference to epilepsy treatment guidelines when applicable
  5. Dosing rationale: Why specific strength/frequency is needed

Clinician Corner: Medical Necessity Letter Checklist

When requesting brand Keppra over generic levetiracetam:

✓ Patient identification: Name, DOB, member ID, diagnosis (ICD-10)
✓ Clinical history: Seizure type, frequency, previous treatments
✓ Generic trial documentation: Dates, dosing, specific outcomes
✓ Failure rationale: Breakthrough seizures, adverse effects, levels
✓ Brand necessity: Why brand formulation is specifically required
✓ Treatment goals: Expected outcomes with brand therapy
✓ Prescriber attestation: Statement of medical necessity

From our advocates: "We've seen the strongest approvals when providers document not just that the generic 'didn't work,' but specifically how seizure control changed—frequency, severity, or breakthrough patterns. Including medication blood levels when available adds objective support to the clinical picture."

Appeals Process in Washington

Washington provides robust protections for patients facing coverage denials through a structured appeals process.

Internal Appeals (Required First Step)

Timeline: 180 days from denial date to file
Levels: Most plans offer 1-2 internal appeal levels
Standard review: Up to 30 days for decision
Expedited review: 72 hours for urgent medical situations

How to file:

  • Submit through UnitedHealthcare member portal
  • Mail to address on denial letter
  • Fax supporting documentation
  • Include all relevant clinical records

External Review (Independent Review Organization)

After exhausting internal appeals, Washington law provides access to independent review through certified Independent Review Organizations (IROs).

Eligibility: Available for any denial based on medical necessity
Timeline: 180 days from final internal denial
Process: Submit request to Office of the Insurance Commissioner
Review time: 30 days for standard, 72 hours for expedited
Binding decision: IRO determination is final and binding on insurer

Washington State Support

Office of the Insurance Commissioner:

  • Phone: 1-800-562-6900 (Consumer Advocacy)
  • Website: Appeals guidance and template letters available
  • Services: Free assistance with appeal preparation and submission

Required Documentation for Appeals

  • Original denial letter
  • All clinical records supporting medical necessity
  • Provider letters of support
  • Previous treatment history
  • Any new clinical information since denial

Coverage Verification Resources

Direct Verification Methods

UnitedHealthcare Member Services:

  • Call number on insurance card
  • Log into member portal for real-time benefits
  • Request formulary status confirmation

OptumRx Pharmacy Services:

  • Phone: 1-800-711-4555
  • Website: professionals.optumrx.com
  • Services: Prior authorization status, formulary lookup

Provider Resources

UnitedHealthcare Provider Portal:

  • Real-time eligibility verification
  • Prior authorization submission and tracking
  • Formulary and coverage policy access

Key Policy Documents:

When to Contact Counterforce Health

Navigating insurance denials for seizure medications can be complex, especially when dealing with prior authorization requirements and appeals processes. Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to craft point-by-point rebuttals aligned with each payer's specific requirements.

For patients and providers dealing with UnitedHealthcare denials for Keppra or other seizure medications, Counterforce Health can help identify the specific denial basis—whether it's step therapy requirements, formulary restrictions, or medical necessity criteria—and develop comprehensive appeals that include the right clinical documentation, medication history, and payer-specific evidence to maximize approval chances.

FAQ

How long does UnitedHealthcare prior authorization take for Keppra in Washington?
Electronic submissions through ePA often receive automated approval in minutes to hours. Manual submissions typically take 24-72 hours for standard review, with expedited options available for urgent medical needs.

What if generic levetiracetam isn't working for my seizures?
Document the specific issues (breakthrough seizures, side effects, inadequate levels) and work with your neurologist to request brand Keppra with medical necessity documentation, or consider alternative seizure medications that may be preferred on your plan.

Can I request an expedited appeal for seizure medication in Washington?
Yes, if your health could be seriously jeopardized by delays, you can request expedited review. Internal appeals must be decided within 72 hours, and external reviews can also be expedited through Washington's IRO process.

Does UnitedHealthcare step therapy apply if I've tried medications outside Washington?
Previous medication trials should count regardless of where they occurred, as long as you have documentation. Include all prior treatment records when submitting prior authorization requests.

What's the difference between a coverage denial and prior authorization requirement?
A prior authorization requirement means the medication can be covered once approved criteria are met. A coverage denial means the medication isn't covered under your plan's formulary, which may require appeals or alternative medication selection.

How do I find an in-network neurologist for seizure treatment in Washington?
Use UnitedHealthcare's online provider directory, or call member services. If no in-network specialists are available within reasonable distance, request a network adequacy exception for in-network coverage rates.

What happens if the external review upholds UnitedHealthcare's denial?
The external review decision is binding, but you can still contact Washington's Office of the Insurance Commissioner to ensure the process was followed correctly, or explore alternative treatment options with your provider.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change over time. Always verify current requirements with UnitedHealthcare directly and consult with your healthcare provider for medical decisions.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.